Advertisement

Complete Regimens

Complete regimens are a fixed-dose combination of HIV drugs. These regimens combine two or more drugs from the same or different classes. 

*generic or biosimilar available

E experimental


DRUG Atripla*
GENERIC NAME efavirenz + tenofovir disoproxil fumarate + emtricitabine
COMPANY Bristol-Myers Squibb and Gilead Sciences
DRUG Biktarvy
GENERIC NAME bictegravir + tenofovir alafenamide + emtricitabine
COMPANY Gilead Sciences
DRUG Cabenuva
Cabenuva
GENERIC NAME cabotegravir + rilpivirine
COMPANY ViiV Healthcare and Janssen Therapeutics
DRUG Complera
GENERIC NAME rilpivirine + tenofovir disoproxil fumarate + emtricitabine
COMPANY Gilead Sciences and Janssen Therapeutics
DRUG Delstrigo
GENERIC NAME doravirine + tenofovir disoproxil fumarate + lamivudine
COMPANY Merck & Company
DRUG Dovato
GENERIC NAME dolutegravir + lamivudine
COMPANY ViiV Healthcare
DRUG Genvoya
GENERIC NAME elvitegravir + cobicistat + tenofovir alafenamide + emtricitabine
COMPANY Gilead Sciences
DRUG Juluca
GENERIC NAME dolutegravir + rilpivirine
COMPANY ViiV Healthcare and Janssen Therapeutics
DRUG Odefsey
GENERIC NAME rilpivirine + emtricitabine + tenofovir alafenamide
COMPANY Gilead Sciences and Janssen Therapeutics
DRUG Stribild
GENERIC NAME elvitegravir + cobicistat + tenofovir disoproxil fumarate + emtricitabine
COMPANY Gilead Sciences
DRUG Symfi and Symfi Lo
GENERIC NAME efavirenz + tenofovir disoproxil fumarate + lamivudine
COMPANY Mylan Pharmaceuticals
DRUG Symtuza
GENERIC NAME darunavir + cobicistat + tenofovir alafenamide + emtricitabine
COMPANY Janssen Therapeutics
DRUG Triumeq
GENERIC NAME dolutegravir + abacavir + lamivudine
COMPANY ViiV Healthcare

Last Reviewed: March 14, 2019


Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.